• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Pfizer Just Canned One of Its Ozempic Killers. What's Next?

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jul 03, 2023 at 10:42: AM
via
  • Pfizer discontinued one of its candidates to treat diabetes and obesity.
  • Even if it hadn't been discontinued, competing medicines would likely win out.
  • Don't hold your breath for the company's other candidate accomplishing much.

article source
 




Top Bottom
Back
Quote